Trader consensus heavily favors no Iranian nuclear weapon before 2027, driven by US-Israeli airstrikes in early 2026 that destroyed key enrichment infrastructure like Natanz's pilot fuel enrichment plant, per IAEA updates. Recent IAEA reports from February and March highlight uncertainty over Iran's 440+ kg stockpile of 60% enriched uranium—possibly relocated underground at Isfahan—but confirm no verified weaponization activities or restarts to weapons-grade levels, aligning with Iran's April envoy statement against bomb-level enrichment. US intelligence assessments reiterate Tehran has not decided to build a bomb, while post-war diplomacy, including UN calls for inspections in potential ceasefires, reinforces barriers amid damaged capabilities and sanctions. Late escalations or hidden breakthroughs could shift odds, but current evidence supports restraint.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$562,723 Vol.
$562,723 Vol.
$562,723 Vol.
$562,723 Vol.
Otherwise, this market will resolve to "No".
Market Opened: Nov 13, 2025, 5:50 PM ET
Resolver
0x65070BE91...Otherwise, this market will resolve to "No".
Resolver
0x65070BE91...Trader consensus heavily favors no Iranian nuclear weapon before 2027, driven by US-Israeli airstrikes in early 2026 that destroyed key enrichment infrastructure like Natanz's pilot fuel enrichment plant, per IAEA updates. Recent IAEA reports from February and March highlight uncertainty over Iran's 440+ kg stockpile of 60% enriched uranium—possibly relocated underground at Isfahan—but confirm no verified weaponization activities or restarts to weapons-grade levels, aligning with Iran's April envoy statement against bomb-level enrichment. US intelligence assessments reiterate Tehran has not decided to build a bomb, while post-war diplomacy, including UN calls for inspections in potential ceasefires, reinforces barriers amid damaged capabilities and sanctions. Late escalations or hidden breakthroughs could shift odds, but current evidence supports restraint.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions